AdvertisementA Decade Marked By Outrage Over Drug PricesDecember 31, 2019Sydney LupkinfacebookEmailMartin Shkreli, former CEO of Turing Pharmaceuticals, appeared before the House Oversight Committee during a contentious hearing on drug pricing on Feb. 4, 2016. (Getty Images)
